Your browser doesn't support javascript.
loading
Activation of pregnane X receptor induces atherogenic lipids and PCSK9 by a SREBP2-mediated mechanism.
Karpale, Mikko; Käräjämäki, Aki Juhani; Kummu, Outi; Gylling, Helena; Hyötyläinen, Tuulia; Oresic, Matej; Tolonen, Ari; Hautajärvi, Heidi; Savolainen, Markku J; Ala-Korpela, Mika; Hukkanen, Janne; Hakkola, Jukka.
Afiliación
  • Karpale M; Research Unit of Biomedicine, University of Oulu, Oulu, Finland.
  • Käräjämäki AJ; Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Kummu O; Biocenter Oulu, University of Oulu, Oulu, Finland.
  • Gylling H; Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Hyötyläinen T; Department of gastroenterology, Clinics of Internal Medicine, Vaasa Central Hospital, Vaasa, Finland.
  • Oresic M; Abdominal Center, Department of Internal Medicine, Oulu University Hospital, Oulu, Finland.
  • Tolonen A; Research Unit of Biomedicine, University of Oulu, Oulu, Finland.
  • Hautajärvi H; Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Savolainen MJ; Biocenter Oulu, University of Oulu, Oulu, Finland.
  • Ala-Korpela M; Heart and Lung Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
  • Hukkanen J; School of Science and Technology, Örebro University, Örebro, Sweden.
  • Hakkola J; School of Medical Sciences, Örebro University, Örebro, Sweden.
Br J Pharmacol ; 178(12): 2461-2481, 2021 06.
Article en En | MEDLINE | ID: mdl-33687065

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Proproteína Convertasa 9 Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Br J Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Finlandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Proproteína Convertasa 9 Tipo de estudio: Clinical_trials Límite: Animals / Humans Idioma: En Revista: Br J Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Finlandia